Astria Therapeutics Stock Target Price and Analyst Consensus
| ATXS Stock | USD 12.95 0.03 0.23% |
The current analyst and expert consensus on Astria Therapeutics is Strong Buy, with 7 strong buy opinions. The current projected Astria Therapeutics target price consensus is 24.60 with 9 analyst opinions. Check out Macroaxis Advice on Astria Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Astria Stock please use our How to Invest in Astria Therapeutics guide.The most common way Astria Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Astria Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Astria Therapeutics. We strongly encourage you to use your own analysis of Astria Therapeutics to validate this buy or sell advice. Astria Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Astria Therapeutics target price to derive its highest and lowest estimates based on projected price volatility of 5.0047.
Lowest Forecast 22.39 | Highest Forecast 27.31 | Target Price 24.6 |
It's important to approach Astria Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Astria Therapeutics price targets
Astria Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Astria Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Astria Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Astria Therapeutics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Astria Therapeutics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Astria Therapeutics is a key component of Astria Therapeutics valuation and have some predictive power on the future returns of a Astria Therapeutics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Astria Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Synthetics Invested over 70 shares | |
 | Macroaxis Index Invested over 20 shares | |
 | Driverless Cars Invested few shares | |
 | Warren Buffett Holdings Invested over 50 shares | |
 | Macroaxis Picks Invested few shares | |
 | Momentum Invested over 200 shares | |
 | Investor Favorites Invested over 20 shares | |
 | Blockchain Invested few shares | |
 | Corona Opportunity Invested few shares | |
 | Hedge Favorites Invested few shares |
Additional Tools for Astria Stock Analysis
When running Astria Therapeutics' price analysis, check to measure Astria Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Astria Therapeutics is operating at the current time. Most of Astria Therapeutics' value examination focuses on studying past and present price action to predict the probability of Astria Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Astria Therapeutics' price. Additionally, you may evaluate how the addition of Astria Therapeutics to your portfolios can decrease your overall portfolio volatility.